chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Injection site rash, Vaccination site erythema
Clinical narrative: red itchy rash on arm at injection site; Very red rash; Very painful; Itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (red itchy rash on arm at injection site), INJECTION SITE RASH (Very red rash), INJECTION SITE PAIN (Very painful) and INJECTION SITE PRURITUS (Itchy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Lactose intolerant. Concomitant products included FAMOTIDINE (PEPCID AC), ZOLPIDEM TARTRATE (AMBIEN), ZALEPLON (SONATA ADAMED), ASCORBIC ACID (VITAMIN C ACID), COLECALCIFEROL (VITAMIN D 3) and FISH OIL (OMEGA 3 COMPLETE) for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 30-Jan-2021, the patient experienced INJECTION SITE RASH (Very red rash), INJECTION SITE PAIN (Very painful) and INJECTION SITE PRURITUS (Itchy). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red itchy rash on arm at injection site). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency. On 06-Feb-2021, VACCINATION SITE ERYTHEMA (red itchy rash on arm at injection site), INJECTION SITE RASH (Very red rash), INJECTION SITE PAIN (Very painful) and INJECTION SITE PRURITUS (Itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Additional info received: concomitant medications updated, current condition updated
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Paraesthesia, Vaccination site pain
Clinical narrative: tingling from the shoulder to the fingers tip; sore arm; sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling from the shoulder to the fingers tip), VACCINATION SITE PAIN (sore arm) and ARTHRALGIA (sore shoulder) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm) and ARTHRALGIA (sore shoulder). On 28-Jan-2021, the patient experienced PARAESTHESIA (tingling from the shoulder to the fingers tip). At the time of the report, PARAESTHESIA (tingling from the shoulder to the fingers tip), VACCINATION SITE PAIN (sore arm) and ARTHRALGIA (sore shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Heart rate, Heart rate increased
Clinical narrative: Rapid pulse and elevated heart rate; TIRED; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Rapid pulse and elevated heart rate) and FATIGUE (TIRED) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included ACICLOVIR, VITAMINS NOS, CALCIUM and METOPROLOL for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced HEART RATE INCREASED (Rapid pulse and elevated heart rate) and FATIGUE (TIRED). On 02-Feb-2021, HEART RATE INCREASED (Rapid pulse and elevated heart rate) had resolved. At the time of the report, FATIGUE (TIRED) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: rapid Rapid pulse and elevated heartrate for a while.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included the patient laying down.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication information was reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 10-Jul-2021: The outcome of the event has been updated from unknown to resolved.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Myalgia
Clinical narrative: Weak/tired coming and going; Aches and pain coming and going; Weak/tired coming and going; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak/tired coming and going), MYALGIA (Aches and pain coming and going) and FATIGUE (Weak/tired coming and going) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Urinary infection.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced ASTHENIA (Weak/tired coming and going), MYALGIA (Aches and pain coming and going) and FATIGUE (Weak/tired coming and going). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 28-Jan-2021, ASTHENIA (Weak/tired coming and going) and FATIGUE (Weak/tired coming and going) was resolving. At the time of the report, MYALGIA (Aches and pain coming and going) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood pressure and cholesterol pills and antibiotics (urine infection). Treatment included some kind of "liquid".
Sex: U
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site pain
Clinical narrative: bilateral hives; pain at the injection site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of URTICARIA (bilateral hives) and VACCINATION SITE PAIN (pain at the injection site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (bilateral hives) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, URTICARIA (bilateral hives) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Positive for covid; A spontaneous report was received from a consumer concerning of an unknown age, female patient, who received Moderna's COVID-19 vaccine and experienced positive for COVID-19 (COVID-19).          The patient's medical history was unknown. Concomitant product details was not provided by the reporter.  On 07 Jan 2021, prior to the onset of events, the patient received her first of two planned doses of mRNA-1273 (Lot number unknown) via unknown route for prophylaxis of COVID-19 infection.    On 14 Jan 2021, the patient tested positive for Covid-19. It is reported that, on 23 Jan 2021, the last symptom was observed. Treatment details was not provided by the reporter.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the event, positive for COVID-19 was unknown.; Reporter's Comments: Very limited information regarding this event has been provided at this time. The patient probably experienced asymptomatic COVID-19 infection before being administered with the mRNA-1273 vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Peripheral swelling
Clinical narrative: severe swelling in her feet and ankles; insomnia; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (severe swelling in her feet and ankles) and INSOMNIA (insomnia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history was reported).   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (severe swelling in her feet and ankles) and INSOMNIA (insomnia). At the time of the report, PERIPHERAL SWELLING (severe swelling in her feet and ankles) and INSOMNIA (insomnia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia
Clinical narrative: body aches; chills; headaches; fatigue; This spontaneous case was reported by a physician and describes the occurrence of MYALGIA (body aches), CHILLS (chills), HEADACHE (headaches) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (body aches), CHILLS (chills), HEADACHE (headaches) and FATIGUE (fatigue). At the time of the report, MYALGIA (body aches), CHILLS (chills), HEADACHE (headaches) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical History reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (reaction). At the time of the report, VACCINATION SITE REACTION (reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Injection site warmth, Myalgia
Clinical narrative: warmth; itchy; ache; redness; chills; Headache; Fatigue; Sore arm; Running nose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Running nose), INJECTION SITE WARMTH (warmth), VACCINATION SITE PRURITUS (itchy), MYALGIA (ache) and VACCINATION SITE ERYTHEMA (redness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no historical condition was reported). Concomitant products included PARACETAMOL (TYLENOL) and ARNICA EXTRACT for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced RHINORRHOEA (Running nose), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Sore arm). On 25-Jan-2021, the patient experienced INJECTION SITE WARMTH (warmth), VACCINATION SITE PRURITUS (itchy), MYALGIA (ache), VACCINATION SITE ERYTHEMA (redness), CHILLS (chills) and HEADACHE (Headache). At the time of the report, RHINORRHOEA (Running nose), INJECTION SITE WARMTH (warmth), VACCINATION SITE PRURITUS (itchy), MYALGIA (ache), VACCINATION SITE ERYTHEMA (redness), CHILLS (chills), HEADACHE (Headache), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: warmth; itchy; ache; redness; chills; Headache; Fatigue; Sore arm; Running nose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Running nose), INJECTION SITE WARMTH (warmth), VACCINATION SITE PRURITUS (itchy), MYALGIA (ache) and VACCINATION SITE ERYTHEMA (redness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no historical condition was reported). Concomitant products included PARACETAMOL (TYLENOL) and ARNICA EXTRACT for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced RHINORRHOEA (Running nose), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Sore arm). On 25-Jan-2021, the patient experienced INJECTION SITE WARMTH (warmth), VACCINATION SITE PRURITUS (itchy), MYALGIA (ache), VACCINATION SITE ERYTHEMA (redness), CHILLS (chills) and HEADACHE (Headache). At the time of the report, RHINORRHOEA (Running nose), INJECTION SITE WARMTH (warmth), VACCINATION SITE PRURITUS (itchy), MYALGIA (ache), VACCINATION SITE ERYTHEMA (redness), CHILLS (chills), HEADACHE (Headache), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VERTIGO (vertigo). At the time of the report, VERTIGO (vertigo) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.   Reporter did not allow further contact
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: soreness in arm; Muscle aches; headache; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm), MYALGIA (Muscle aches), HEADACHE (headache), CHILLS (Chills) and PYREXIA (Fever) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included MIRABEGRON (MYRBETRIQ) for an unknown indication.   On 20-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm), MYALGIA (Muscle aches), HEADACHE (headache), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (soreness in arm), MYALGIA (Muscle aches), HEADACHE (headache), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Nonsignificant Followup appended
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: a little lump that I had under my skin; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (a little lump that I had under my skin) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (a little lump that I had under my skin). At the time of the report, VACCINATION SITE MASS (a little lump that I had under my skin) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: A little dizziness; Vomiting feeling; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (A little dizziness) and NAUSEA (Vomiting feeling) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Prostate cancer.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced DIZZINESS (A little dizziness) and NAUSEA (Vomiting feeling). At the time of the report, DIZZINESS (A little dizziness) outcome was unknown and NAUSEA (Vomiting feeling) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Patient took no treatment for events.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity
Clinical narrative: still have a lot of pain and soreness in my arm; still have a lot of redness in my arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (still have a lot of pain and soreness in my arm) and ERYTHEMA (still have a lot of redness in my arm) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (still have a lot of pain and soreness in my arm) and ERYTHEMA (still have a lot of redness in my arm). At the time of the report, PAIN IN EXTREMITY (still have a lot of pain and soreness in my arm) was resolving and ERYTHEMA (still have a lot of redness in my arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Red Spot; Red spot came back and it was itchy; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red Spot) and PRURITUS (Red spot came back and it was itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red Spot) and PRURITUS (Red spot came back and it was itchy). At the time of the report, ERYTHEMA (Red Spot) and PRURITUS (Red spot came back and it was itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site oedema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: raised area at injection site; itchy area on injection site; Swollen injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE OEDEMA (raised area at injection site), VACCINATION SITE PRURITUS (itchy area on injection site) and VACCINATION SITE SWELLING (Swollen injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE OEDEMA (raised area at injection site), VACCINATION SITE PRURITUS (itchy area on injection site) and VACCINATION SITE SWELLING (Swollen injection site). At the time of the report, VACCINATION SITE OEDEMA (raised area at injection site), VACCINATION SITE PRURITUS (itchy area on injection site) and VACCINATION SITE SWELLING (Swollen injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Sore Arm; Chills; Body Aches; Fever; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), CHILLS (Chills), MYALGIA (Body Aches) and PYREXIA (Fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025120A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (was tested negative on 28-dec-2020) on 14-Dec-2020. Concurrent medical conditions included Blood pressure abnormal.    On 08-Jan-2021 at 3:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm), CHILLS (Chills), MYALGIA (Body Aches) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Sore Arm), CHILLS (Chills), MYALGIA (Body Aches) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Dec-2020, COVID-19: positive (Positive) Positive. On 28-Dec-2020, COVID-19: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitantly, patient was taking unspecified medication for blood pressure. No treatment related information has been reported.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Peripheral swelling
Clinical narrative: Feet, legs, calves swelling; Breast hurt; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Feet, legs, calves swelling) and BREAST PAIN (Breast hurt) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced PERIPHERAL SWELLING (Feet, legs, calves swelling) and BREAST PAIN (Breast hurt). At the time of the report, PERIPHERAL SWELLING (Feet, legs, calves swelling) and BREAST PAIN (Breast hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Products known to have been used by the patient, within two weeks prior to the event, included eye vitamin.  Patient is taking Lasix PRN for swelling but not helping much.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Redness at injection site; Itchiness at injection site; Redness at injection site; Soreness at injection site; A spontaneous report was received from a consumer, concerning herself, a 72-year-old female patient, who received Moderna's COVID-19 vaccine and experienced rash at injection site, redness at injection site, itchiness at injection site and soreness at injection site.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 22 Jan 2021, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 in her left upper arm (Lot number: unknown) for prophylaxis of Covid-19 infection.  On 22 Jan 2021, after vaccination, the patient experienced  rash, redness, itchiness and soreness at injection site. However, soreness went away within few days but the other symptoms were still ongoing. No treatment information was provided.  Action taken with mRNA-1273 in response to the events were unknown.  The outcome of the events, rash at injection site, redness at injection site, itchiness at injection site and soreness at injection site were considered not resolved at the time of this report. The outcome of event soreness at injection site was considered resolved on an unspecified date in 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Eyelid disorder, Hypertension, Paraesthesia oral, Swelling face
Clinical narrative: BP  was a little bit high; my face swelled up; tongue, lip, and palette were tingling for 3 days; I could feel my eyelids were popping; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (BP  was a little bit high), SWELLING FACE (my face swelled up), PARAESTHESIA ORAL (tongue, lip, and palette were tingling for 3 days) and EYELID DISORDER (I could feel my eyelids were popping) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: EPIPEN (Allergy shot; Lot: 042l20A).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HYPERTENSION (BP  was a little bit high), SWELLING FACE (my face swelled up), PARAESTHESIA ORAL (tongue, lip, and palette were tingling for 3 days) and EYELID DISORDER (I could feel my eyelids were popping). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing from 21-Jan-2021 at a dose of 60 milligram three times a day and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 22-Jan-2021 to 25-Jan-2021 at a dose of 25 milligram. On 21-Jan-2021, HYPERTENSION (BP  was a little bit high) and EYELID DISORDER (I could feel my eyelids were popping) had resolved. On 24-Jan-2021, PARAESTHESIA ORAL (tongue, lip, and palette were tingling for 3 days) had resolved. At the time of the report, SWELLING FACE (my face swelled up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cold sweat, Influenza like illness, Lethargy, Pain
Clinical narrative: Flu-like Symptoms; Cold sweats; Pain; Lethargic; Fever 102 F; Arm swollen; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like Symptoms), COLD SWEAT (Cold sweats), PAIN (Pain), LETHARGY (Lethargic) and PYREXIA (Fever 102 F) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 02-Jan-2021.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like Symptoms), COLD SWEAT (Cold sweats), PAIN (Pain), LETHARGY (Lethargic), PYREXIA (Fever 102 F) and VACCINATION SITE SWELLING (Arm swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 30-Jan-2021, INFLUENZA LIKE ILLNESS (Flu-like Symptoms), COLD SWEAT (Cold sweats), PAIN (Pain), LETHARGY (Lethargic), PYREXIA (Fever 102 F) and VACCINATION SITE SWELLING (Arm swollen) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. On 29-Jan-2021, Body temperature: 102 °F (High) 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Vaccination site swelling
Clinical narrative: Flu-like Symptoms; Cold sweats; Pain; Lethargic; Fever 102 F; Arm swollen; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like Symptoms), COLD SWEAT (Cold sweats), PAIN (Pain), LETHARGY (Lethargic) and PYREXIA (Fever 102 F) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 02-Jan-2021.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like Symptoms), COLD SWEAT (Cold sweats), PAIN (Pain), LETHARGY (Lethargic), PYREXIA (Fever 102 F) and VACCINATION SITE SWELLING (Arm swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 30-Jan-2021, INFLUENZA LIKE ILLNESS (Flu-like Symptoms), COLD SWEAT (Cold sweats), PAIN (Pain), LETHARGY (Lethargic), PYREXIA (Fever 102 F) and VACCINATION SITE SWELLING (Arm swollen) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. On 29-Jan-2021, Body temperature: 102 °F (High) 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, SARS-CoV-2 test
Clinical narrative: Chest pain; Tested positive for COVID; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (Chest pain) and COVID-19 (Tested positive for COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain) and COVID-19 (Tested positive for COVID). At the time of the report, CHEST PAIN (Chest pain) and COVID-19 (Tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  Treatment for the event chest pain included antiallergics.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Herpes zoster, Pain, Pruritus
Clinical narrative: Terrible shingles; Diarrhea worsened; Crazy itching, itching on leg, fingers and feels like spreading; Aching; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Terrible shingles), DIARRHOEA (Diarrhea worsened), PRURITUS (Crazy itching, itching on leg, fingers and feels like spreading) and PAIN (Aching) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Shingles. Concurrent medical conditions included Diarrhea. Concomitant products included ALENDRONATE SODIUM (ALENDRONATE), BIFIDOBACTERIUM INFANTIS (ALIGN), DOXYCYCLINE MONOHYDRATE, FLUOXETINE HYDROCHLORIDE (PROZAC), LEVOTHYROXINE, TORSEMIDE, PREDNISONE and CICLOPIROX OLAMINE (LOPROX) for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced DIARRHOEA (Diarrhea worsened), PRURITUS (Crazy itching, itching on leg, fingers and feels like spreading) and PAIN (Aching). On 20-Jan-2021, the patient experienced HERPES ZOSTER (Terrible shingles). The patient was treated with CLOBETASOL (topical) at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Terrible shingles) and PRURITUS (Crazy itching, itching on leg, fingers and feels like spreading) had not resolved and DIARRHOEA (Diarrhea worsened) and PAIN (Aching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event included cold compress, and CBD deep relief cream.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jan-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Arm is hurting, is really sore, can't even lift it - second dose; A little pain if she pushed on the area - first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is hurting, is really sore, can't even lift it - second dose) and VACCINATION SITE PAIN (A little pain if she pushed on the area - first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm is hurting, is really sore, can't even lift it - second dose) and VACCINATION SITE PAIN (A little pain if she pushed on the area - first dose). At the time of the report, PAIN IN EXTREMITY (Arm is hurting, is really sore, can't even lift it - second dose) and VACCINATION SITE PAIN (A little pain if she pushed on the area - first dose) outcome was unknown. Not Provided          No relevant concomitant medications were reported.  No treatment information was provided. Action taken with mRNA-1273 is not applicable
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: fever; swelling was bigger than 1st day; Painful; painful; Vaccination site hot to touch; Injection site swelling; Injection site pain; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site hot to touch), VACCINATION SITE SWELLING (Injection site swelling), VACCINATION SITE PAIN (Injection site pain), PYREXIA (fever) and VACCINATION SITE SWELLING (swelling was bigger than 1st day) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Crohn's disease, Hashimoto's thyroiditis, GERD and Ulcerative colitis. Concurrent medical conditions included Adhesive tape allergy. Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE PAIN (Injection site pain). On 02-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site hot to touch), PYREXIA (fever), VACCINATION SITE SWELLING (swelling was bigger than 1st day), VACCINATION SITE PAIN (Painful) and PAIN (painful). At the time of the report, VACCINATION SITE WARMTH (Vaccination site hot to touch), PYREXIA (fever), VACCINATION SITE SWELLING (swelling was bigger than 1st day), VACCINATION SITE PAIN (Painful) and PAIN (painful) outcome was unknown and VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE PAIN (Injection site pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   treatment medications were not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: tested positive for COVID-19; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID-19) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011l20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 25-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID-19). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included monoclonal antibody infusion No relevant concomitant medications were reported.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Lymphadenopathy, Pain
Clinical narrative: Super heavy period; Soreness; Swollen lymph node; This spontaneous case was reported by a  and describes the occurrence of PAIN (Soreness), HEAVY MENSTRUAL BLEEDING (Super heavy period) and LYMPHADENOPATHY (Swollen lymph node) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2020, the patient experienced LYMPHADENOPATHY (Swollen lymph node). On 22-Jan-2021, the patient experienced PAIN (Soreness). On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (Super heavy period). On 25-Jan-2021, LYMPHADENOPATHY (Swollen lymph node) was resolving. At the time of the report, PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-Feb-2021: No specific follow-up information recorded.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain in extremity, Pyrexia
Clinical narrative: sore arm; Fever of 102°C; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PYREXIA (Fever of 102°C) and CHILLS (chills) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PYREXIA (Fever of 102°C) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (sore arm), PYREXIA (Fever of 102°C) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Body temperature: 102 (High) fever of 102°C.         Concomitant medications was not provided by the reporter.  No treatment information was provided.  Action taken with mRNA-1273  in response to the event was not applicable.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Eating disorder, Fatigue, Hyperhidrosis
Clinical narrative: SWEAT; ost many pounds; ositive for covid; could not eaT; tired; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (SWEAT), WEIGHT DECREASED (ost many pounds), SARS-COV-2 TEST POSITIVE (ositive for covid), EATING DISORDER (could not eaT) and FATIGUE (tired) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No Medical History was reported). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) and IBUPROFEN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (SWEAT), WEIGHT DECREASED (ost many pounds), SARS-COV-2 TEST POSITIVE (ositive for covid), EATING DISORDER (could not eaT), FATIGUE (tired), PYREXIA (fever) and CHILLS (chills). At the time of the report, HYPERHIDROSIS (SWEAT), WEIGHT DECREASED (ost many pounds), SARS-COV-2 TEST POSITIVE (ositive for covid), EATING DISORDER (could not eaT), FATIGUE (tired), PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information include infusion.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Weight decreased
Clinical narrative: SWEAT; ost many pounds; ositive for covid; could not eaT; tired; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (SWEAT), WEIGHT DECREASED (ost many pounds), SARS-COV-2 TEST POSITIVE (ositive for covid), EATING DISORDER (could not eaT) and FATIGUE (tired) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No Medical History was reported). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) and IBUPROFEN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (SWEAT), WEIGHT DECREASED (ost many pounds), SARS-COV-2 TEST POSITIVE (ositive for covid), EATING DISORDER (could not eaT), FATIGUE (tired), PYREXIA (fever) and CHILLS (chills). At the time of the report, HYPERHIDROSIS (SWEAT), WEIGHT DECREASED (ost many pounds), SARS-COV-2 TEST POSITIVE (ositive for covid), EATING DISORDER (could not eaT), FATIGUE (tired), PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information include infusion.